Literature DB >> 3428283

A high efficiency ultrasound nebuliser for radioaerosol studies of the lungs.

M Pillay1, J A Akkermans, P H Cox.   

Abstract

An ultrasound nebuliser with variable delivery temperature and nebulisation volume was tested for particle size distribution, efficiency, and application in a clinical environment. The results obtained comply with our criteria for a general purpose radioaerosol generating system for use in evaluating various parameters of lung function.

Mesh：

Substances：

Year:  1987        PMID： 3428283     DOI： 10.1007/BF00252989

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  4 in total

1.  Radioaerosol assessment of mucociliary clearance: towards definition of a normal range.

Authors:  J E Agnew; P P Sutton; D Pavia; S W Clarke
Journal:  Br J Radiol       Date:  1986-02       Impact factor: 3.039

2.  Increased alveolar epithelial permeability in cigarette smokers.

Authors:  J G Jones; B D Minty; P Lawler; G Hulands; J C Crawley; N Veall
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

3.  Physical properties of aerosols produced by several jet- and ultrasonic nebulizers.

Authors:  P J Sterk; A Plomp; J F van de Vate; P H Quanjer
Journal:  Bull Eur Physiopathol Respir       Date:  1984 Jan-Feb

4.  Nasal mucociliary transport in laryngectomees.

Authors:  J Pavía; A García; R Abelló; M Franch; R de España; R Herranz
Journal:  Eur J Nucl Med       Date:  1986
  4 in total
  3 in total

Review 1.  Aerosols for therapy and diagnosis.

Authors:  M J O'Doherty; R F Miller
Journal:  Eur J Nucl Med       Date:  1993-12

2.  The stability of 99mTc-DTPA and 99mTc-HIDA following ultrasonic nebulisation.

Authors:  N Durovic; M Pillay; P H Cox
Journal:  Eur J Nucl Med       Date:  1988

3.  Preparation of a fine powder of 2-deoxy-2-[18F]fluoro-D-glucose suitable for inhalation to diagnose lung diseases by means of PET.

Authors:  F Ojima; T Ido; T Takahashi; J Hatazawa; M Ito; H Sasaki; M Yanai; T Aikawa; T Takishima; K Abiko
Journal:  Ann Nucl Med       Date:  1989-11       Impact factor: 2.668
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.